- MediPharm Labs (OTCQB:MEDIF) said it will sell its facility in Napanee to Kensana Health for $5.5 million in cash.
- The deal is through a disposition of all of the company’s indirect equity interests in its unit ABcann Medicinals.
- Kensana Health will acquire

